Cigna Group (NYSE:CI – Get Free Report) insider Nicole Jones sold 19,436 shares of Cigna Group stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider directly owned 27,256 shares in the company, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Cigna Group Stock Up 2.4%
Cigna Group stock opened at $281.95 on Friday. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The firm has a market cap of $74.50 billion, a P/E ratio of 11.67, a P/E/G ratio of 0.95 and a beta of 0.29. The business has a fifty day moving average of $286.00 and a two-hundred day moving average of $281.20. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47.
Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The business had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business’s revenue was up 6.7% compared to the same quarter last year. During the same period last year, the business posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, analysts forecast that Cigna Group will post 30.51 earnings per share for the current fiscal year.
Cigna Group Announces Dividend
Hedge Funds Weigh In On Cigna Group
Several hedge funds have recently modified their holdings of CI. Vanguard Group Inc. grew its position in Cigna Group by 1.6% during the 4th quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock worth $7,203,754,000 after purchasing an additional 414,834 shares during the last quarter. BlackRock Inc. raised its holdings in shares of Cigna Group by 3.7% in the second quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock worth $6,461,457,000 after buying an additional 840,098 shares during the last quarter. State Street Corp lifted its stake in shares of Cigna Group by 1.8% during the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock worth $3,396,132,000 after buying an additional 224,122 shares during the period. Massachusetts Financial Services Co. MA lifted its stake in shares of Cigna Group by 8.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after buying an additional 903,334 shares during the period. Finally, Dodge & Cox grew its holdings in shares of Cigna Group by 19.7% during the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after buying an additional 1,833,389 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on CI shares. UBS Group raised their price target on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Sanford C. Bernstein increased their target price on shares of Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. Wall Street Zen downgraded shares of Cigna Group from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Mizuho lifted their price target on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Finally, Barclays upped their price target on Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Fifteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $339.45.
View Our Latest Analysis on CI
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
See Also
- Five stocks we like better than Cigna Group
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
